chloroquine has been researched along with unc 0638 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, KT; Arimondo, PB; Bouchut, A; Chua, MJ; Fabrizi, G; Hoglund, U; Khalife, J; Lafitte, S; Lucidi, A; Mai, A; Mazzone, R; Pechalrieu, D; Pierrot, C; Rotili, D; Schultz, J; Skinner-Adams, TS; Valente, S | 1 |
| Chng, WJ; Dymock, BW; Fang Nee, AH; Haider, S; Mustafa, N; Ramanujulu, PM; Soumyanarayanan, U; Tan, KSW; Tong, JX | 1 |
2 other study(ies) available for chloroquine and unc 0638
| Article | Year |
|---|---|
Identification of novel quinazoline derivatives as potent antiplasmodial agents.
Topics: Animals; Antimalarials; Dose-Response Relationship, Drug; Fibroblasts; Humans; Mice; Mice, Inbred BALB C; Molecular Conformation; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Quinazolines; Structure-Activity Relationship | 2019 |
Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor.
Topics: Animals; Antimalarials; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Mice; Microsomes, Liver; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Rats; Structure-Activity Relationship | 2019 |